Insulin Injection Pen - ANVISA Registration 82323499002
Access comprehensive regulatory information for Insulin Injection Pen in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82323499002 and manufactured by GANGAN MEDICAL TECHNOLOGY JIANGSU CO., LTD. The registration is held by GAN & LEE PHARMACEUTICALS DO BRASIL COMERCIO E IMPORTADORA DE MEDICAMENTOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including WOCKHARDT LIMITED, NOVO NORDISK A/S, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
82323499002
25351115429202265
41897436000102
Company Information
Dates and Status
Jun 30, 2022
VIGENTE
09/18/2025 19:00:01
Caneta Para Injecao de Insulina
DuraTouchยฎ
NOVO NORDISK A/S
82113069007
Mar 24, 2025
Caneta Para Injecao de Insulina
INSUWOK PEN
WOCKHARDT LIMITED
80695719036
Mar 17, 2025
Caneta Para Injecao de Insulina
NovoPen 4
NOVO NORDISK A/S
82113069005
May 20, 2024
Caneta Para Injecao de Insulina
NovoPen Echo
NOVO NORDISK A/S
82113069006
May 20, 2024
Caneta Para Injecao de Insulina
mypen 2
WOCKHARDT LIMITED
80410389002
May 29, 2023

